Short-Term Dapagliflozin Administration in Autosomal Dominant Polycystic Kidney Disease—A Retrospective Single-Arm Case Series Study

Treatment with sodium-glucose cotransporter-2 (SGLT2) inhibitors may have pleiotropic and beneficial effects in terms of ameliorating of risk factors for the progression of autosomal dominant polycystic kidney disease (ADPKD). However, there is insufficient evidence regarding the use of these drugs...

Descripción completa

Detalles Bibliográficos
Autores principales: Morioka, Fumiyuki, Nakatani, Shinya, Uedono, Hideki, Tsuda, Akihiro, Mori, Katsuhito, Emoto, Masanori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573882/
https://www.ncbi.nlm.nih.gov/pubmed/37834985
http://dx.doi.org/10.3390/jcm12196341

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573882/
https://www.ncbi.nlm.nih.gov/pubmed/37834985
http://dx.doi.org/10.3390/jcm12196341

Ejemplares similares